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Abstract  
 
The in vivo observation of the human retina at the cellular level is crucial to detect lesions 
before irreversible visual loss occurs, to follow the time course of retinal diseases and to 
evaluate and monitor the early effects of treatments. Despite the phenomenal advances in 
optical coherence tomography (OCT) and adaptive optics systems, in vivo imaging of several 
retinal cells is still elusive.  
Here we propose a radically different method compared to OCT, called transscleral optical 
phase imaging (TOPI), which allows to image retinal cells with high contrast, high resolution, 
and within an acquisition time suitable for clinical use.  TOPI relies on high-angle oblique 
illumination of the retina, combined with adaptive optics, to enhance the phase contrast of 
transparent cells.  
We first present in-vivo images of retinal cells, from the retinal pigment epithelium (RPE) to 
the nerve and vascular layers of the retina, in eleven healthy volunteers without pupil dilation.  
The morphology of the cells in vivo is then compared to that of images obtained with the 
same technique applied on ex vivo human RPE and pig retinas. Finally, we demonstrate the 
ability of high resolution phase microscopy to image pericytes and microglia around rat 
retinal capillaries.  
Our results show the ability of TOPI to image and quantify retinal cells up to the RPE depth 
within a maximum time of 9 seconds over a field of view of 4.4 x 4.4°, opening new avenue 
in the in vivo exploration of the deepest layer of the retina in healthy and diseased eyes.  
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Introduction  
 
Retinal diseases are the major cause of blindness in industrialized countries. For 
example, an estimated total of 196 million people will be affected by age related macular 
degeneration in 2020 [1]. While tremendous effort is being made to develop novel therapeutic 
strategies to rescue retinal neurons and the retinal pigment epithelium, optimal means for 
evaluating the effects of such treatments are still missing.  
Optical coherence tomography/microscopy (OCT/OCM) is a well-established depth-
resolved imaging method used in ophthalmology. Together with scanning laser 
ophthalmoscope (SLO), they constitute the toolbox for routine eye fundus examination. 
However, minute changes in cell morphology which may be present during the early stages of 
disease progression cannot yet be quantified via commercial OCT or SLO systems. Therefore, 
the development of methods that can extract and quantify such small morphological changes 
in retinal cells at different depths is of considerable interest for new therapeutic approaches. 
The retina is composed of many vascular and cellular layers, forming an intricate and 
complex tissue. Individual cell imaging in the retina is very challenging due to many 
constraints such as ocular aberration reducing lateral resolution, eye motion artifacts and, a 
lack of good contrast of transparent cells. Indeed, to ensure proper transmission of incident 
photons, the different layers laying anterior to the photoreceptors are well index-matched and 
transparent. On the other hand, the layers located posterior to the photoreceptors are difficult 
to visualize because most of the light is either absorbed or reflected at the photoreceptors 
interface, letting only few photons reaching the retinal pigment epithelium (RPE).  
The use of adaptive optics (AO) to correct ocular aberration has enabled the imaging 
of the photoreceptor mosaic using both flood illumination [2] and scanning systems (AO-
OCT, AO-SLO) [3] [4]. The contrast of the photoreceptor cells is obtained thanks to the high-
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reflection produced at the cell inner-outer segments interface [5] and posterior tip of the outer 
segment [6].  This relative high reflectivity is maximum for an illumination beam entering the 
eye pupil center and decreases sharply when entering close to the pupil edge making a larger 
illumination angle. The angular-dependent reflection of the retina has been extensively 
documented and is commonly known as optical Stiles-Crawford effect (SCE). SCE is due to 
the waveguiding properties of the photoreceptors that was first observed in the context of light 
perception by Stiles and Crawford in 1933 [7]. In recent works, optical methods to observe 
the neuroretina and the RPE cells were proposed using modified AO-SLO with offset aperture 
[8] [9] [10] or split detector setups [11] [12] [13].  However, due to the safety limitations in 
retinal illumination levels in humans, the signal-to-noise ratio of cell images was low [14]. In 
a recent study, Liu et al. [15] used an AO-OCT system to obtain high-resolution images of the 
neuroretina and the RPE. This optimized setup had enough resolution and sensitivity to detect 
signals from the organelles which were continuously moving within the cell soma. By 
averaging more than 100 images over a time span of approximately 10 minutes, in vivo 
images of ganglion somas and RPE cells were achieved. Despite the good quality of the 
images, this advanced OCT-AO technique is fundamentally limited by the biological time 
constant of organelle motility [16], which leads to an acquisition time that is still too slow for 
clinical use. 
Here, we propose a method that circumvents the acquisition time limitation due to 
organelles motility and the contrast limitation resulting from trans-pupil illumination to 
provide cellular-resolution label-free high-contrast images of the retina layers. This method is 
based on transscleral flood illumination of the retina as illustrated in Fig. 1. Transscleral 
illumination has been used for decades for diagnostic in oncology and for retinal surgery but 
has never been used for cellular imaging [17]. The light transmitted through the sclera allows 
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an oblique illumination of the posterior retina, which is then imaged using a trans-pupillary 
adaptive-optics full-field camera system. We call this imaging modality “TOPI” for Trans-
scleral Optical Phase Imaging. As compared to scanning systems, this flood illumination 
technique is less sensitive to eye-motion artifacts since all the pixels are recorded 
simultaneously with a short acquisition time (few ms). Transscleral illumination has two 
interesting properties that compensate the low contrast of the retina observed with trans-pupil 
flood illumination. Firstly, due to the SCE, almost no high angle illumination light is coupled 
into the photoreceptors, allowing a large fraction of the illuminating light to reach the RPE 
layer. Secondly, no direct illumination light is collected by the imaging system because there 
is no overlap with the collection path. Only the light back-scattered by the different retina 
layers reaches the camera thus providing a darkfield imaging condition. 
 In this study, we first show that, by combining transscleral imaging and AO, our 
method allows visualization of RPE cells and other retinal structures at different areas of the 
fundus in eleven subjects. The potential of this technology is then validated ex-vivo using an 
experimental phase microscope with parameters similar to those of in vivo imaging. Finally, 
we present high resolution phase images of retinal capillaries taken under the phase 
microscope optimized for cell microscopy.  
 
Results 
Transscleral Optical Phase Imaging of the retina 
TOPI images were acquired using our experimental setup (Fig. S 1), in healthy 
volunteers, in dark room conditions without pupil dilation.  The pupil diameter ranged from 4 
to 7 mm. Images were taken at different depths, from the RPE to the inner retina.  
In vivo, 4.4°×4.4 imaging of the retinal pigment epithelium within seconds 
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The RPE layer from a healthy volunteer is exemplified in Fig. 2 (see Fig. S 2 for 
images in two additional volunteers). Due to the low signal over noise ratio (SNR) of the raw 
images coming from the retina, the in vivo TOPI image was processed using a recorded 
sequence of 100 images taken within a total acquisition time of 9 seconds. Due to the 
absorbing pigments in the cell soma, individual RPE cells are clearly visible on the full image 
with a dark center and bright edges.  The low reflectivity of the cone mosaic caused by the 
high angle illumination is not shadowing the signal from the RPE cells underneath.  Due to 
the large depth-of-field (i.e. ∼20 μm), a lower spatial frequency bright-and-dark “cloudy” 
modulation is partially overlapping the RPE cellular mosaic. This unwanted signal is coming 
from the non-uniform pigmentation of the epithelium and from the out-of-focus light 
backscattered from the choroid located below. This modulation can be partially removed by 
post-processing the final image with a high-pass filter. The high-pass result is illustrated in 
Fig. 2B where the cell mosaic is easier to visualize.  
Fig. 2A shows an example of the wide field-of-view image (4.4°×4.4°) obtained with 
the TOPI system in less than 10 seconds while providing cellular resolution. In comparison, 
an AO-OCT system of similar spatial resolution has a significantly smaller field of view of 
1.5°x1.5° and takes several minutes to obtain a similar image [18].  
 
RPE cells size and density. 
RPE imaging was performed in eleven healthy volunteers (from 19 to 49 years-old). 
No major difference was noticed in the RPE images from the subjects with different skin and 
RPE pigmentations, demonstrating that TOPI could be used in patients of different phototypes 
[19]. The RPE cells quantification between 2° and 12° eccentricity gives an average area of 
241 ± 29 µm2 (Fig. 3A) for an average density of 4371 ± 460 cells/mm2 (Fig. 3B). 
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Interestingly, the youngest participant presented the highest density of RPE cells, whereas the 
oldest participant presented the lowest density (Fig. 3C). 
This quantitative analysis matched the values found in the literature at these 
eccentricities [15], [18]. One in-vivo autofluorescence AO-SLO study provided a RPE cell 
density of 5890 cells/mm2 (168 µm2 area) and 5630 cells/mm2 (195 µm2 area) at 5° and 6.25° 
respectively (2 subjects) [20]. Another AO-OCT study reported a mean density at 3° of 4975 
± 651 cells/mm2 (6 subjects) [18]. From these three in-vivo measurements, no significant 
difference appears with respect to our data (P>0.05 for the three comparisons).  Scoles et  al. 
reported, from histological study in the macula, an average density of 5662 cells/mm2 and an 
average cell area of 160 µm2 for age below 60 (6 samples) [21]. This density represents no 
significant difference with our data (P=0.296). Moreover, the row to row spacing of 13.8 µm 
extracted from Fourier analysis of the images (Fig. S 3) is the same as a previously reported 
value obtained with AO-OCT [18]. We also show on Fig. S 4B and C a stitched image of the 
RPE layer over 27° horizontally since our system allows imaging over a range of ±15° both 
vertically and horizontally (Fig. S 4A) . Finally, the SNR analysis presented in Fig. S 5 shows 
that an acquisition time as low as two seconds provides a suitable TOPI image for RPE 
quantification. 
 
In vivo imaging of the nerve fiber layer (NFL). 
 By axially shifting the focal plane of the imaging system, other layers of the neural 
retina can be observed, as shown in Fig. 4 on a 3°×3° cropped version of the full TOPI image 
for better visualization. The location of each crop is shown on the fundus image taken with an 
Optos SLO (Fig. 4A). Images of the vascular layer (Fig. 4B-C) and the nerve fiber layer (Fig. 
4D-E-F) are shown. On the top row, retinal capillaries as small as few-microns can be seen 
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and on the bottom row, the NFL at different eccentricities are imaged. Large axon bundles of 
30-50 μm diameter are clearly visible and well-aligned in the direction of the optical nerve. 
The ability to observe very small capillaries and axons bundles comes from the dark-field 
effect of the transscleral illumination where the signal of the translucent structure is not buried 
under the illumination light. 
 
Comparison between transscleral and transpupillary illumination  
We then compared the commercial rtx1 AO retinal camera (Imagine Eyes), using 
flood transpupillary illumination, with our TOPI camera, using transscleral oblique 
illumination, in the same area of the subject S10’s fundus as shown in the NFL images (Fig. 
5A-D). The transpupillary illumination in rtx1 allows better visualization of the 
photoreceptors than TOPI images (Fig. 5B-E). This is due to the optical SCE at the inner-
outer segment interface which provides a high reflectivity when light is incident perpendicular 
to the retina [22]. The strong cone signal produced by transpupillary illumination masks the 
adjacent layers, particularly the posterior RPE where only defocused photoreceptor light is 
visible (Fig. 5C). On the contrary, using transscleral illumination, cones produce a very weak 
signal, and thus the RPE cells appear well-contrasted (Fig. 5F). These results clearly confirm 
the very interesting properties of transscleral illumination for imaging the deepest layer of the 
retina. 
 
ex vivo validation of the proposed phase imaging modality  
Our experimental phase microscope is illustrated in Fig. S 6. In a first series of 
experiments, it has been configured to obtain similar optical conditions to those of the in-vivo 
implementation in order to validate the potential of phase imaging with oblique illumination, 
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without the artefacts induced by eye movements and aberrations. For this purpose, an 
objective with a numerical aperture (NA) of 0.25 was selected to match the maximum 
possible numerical aperture of a fully dilated human eye (0.24). Four light emitting diodes 
(LEDs) with a center wavelength of 650 nm and a 50 nm bandwidth were used to illuminate 
the retina.  The ex-vivo image reconstruction is described in the Materials and Methods 
section. To mimic the scattering effect of the sclera, a white paper sheet was placed between 
the LEDs and the samples (Fig. S 6D).  
 
Optical characterization of ex-vivo images 
We first measured the modulation transfer function (MTF) resulting from the 
incoherent illumination (Fig. S 7A). Then, we performed imaging of the frontal frozen 
sections of a pig neuroretina to compare our phase imaging method with digital holographic 
microscopy (DHM). For phase imaging, a scattering surface (standard printer white paper) 
was attached to the bottom side of the glass slide in order to simulate the back-scattered light 
(Fig. S 6B). DHMs produce true metrological phase images, allowing for a quantitative 
comparison with the proposed method Fig. S 7B). The images from the DHM were taken with 
a 0.4-NA microscope objective and with coherent light illumination. Because our method uses 
incoherent light, the cut-off spatial frequency was equal to 
     , with λ 
being the central illumination wavelength. Thus, our phase imaging method produces images 
with a resolution similar to the 0.4-NA DHM images taken with coherent illumination and 
with a sharp cut-off spatial frequency of 
  . 
Finally, we compared our phase imaging modality with reflectance confocal 
microscopy using a human retina-choroid complex. The back illumination was provided by 
the scattering of the RPE-choroid layers (Fig. S 6C), and the region of interest was selected 
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using blood vessels as landmarks. Fig. S 7C shows the intensity images taken with a confocal 
microscope and 0.8-NA (left) and 0.3-NA (center) objectives. Our phase image (right), which 
was recorded at the same depth, exhibits better SNR and resolution than the 0.3-NA confocal 
microscope image. In addition, compared with the 0.8-NA image, the phase image makes 
other features visible, such as blood cells into the vessels and other retinal cellular structures 
outside of the vessels.  
 
Validation of phase imaging of retinal layers  
A second healthy human retina-choroid complex was observed ex vivo to validate, 
under steady conditions, the morphology of the RPE cell imaged in healthy volunteers. The 
microscope was set with one LED to mimic the in vivo set up and with a 0.17 NA objective to 
mimic a pupil without dilation. As in in vivo phase images, RPE cells appeared with a dark 
center and bright edges in the ex vivo dark-field images of the human RPE (Fig. S 8). This 
feature has also been observed in dark-field AO-SLO [23]. 
The phase microscope set with four LEDs and the 0.25 NA objective lens was then 
used to demonstrate the depth-resolution of our phase modality. Depth scanning was achieved 
by moving the sample axially, following the z-axis. Thanks to the objective’s 10 µm depth of 
field, all layers of the 200-µm-thick neuroretina on a pig retina-choroid complex were 
visualized in the area centralis [24] (Fig. 6A, C, E, G, I, K). The raw phase images were 
processed in order to digitally tag cell nuclei in each layer (Fig. 6B, D, F, H, J, L), and thus to 
quantify cell densities in the ganglion cell layer (2’260 cells/mm2), the inner nuclear layer 
(9’744 cells/mm2), the outer nuclear layer (23’790 cells/mm2), and the photoreceptor layer 
(20’930 cells/mm2) (Fig. 6M, blue curves). These results were compared with the data 
available in the literature, and we found that the measured ganglion cell and cone densities are 
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consistent with the reported ganglion cells (1500 to 4000 cells/mm2, [25]) and cones (19000 
[24] to 22600 [26] cells/mm2) densities. 
 
High resolution phase microscopy of retinal capillaries 
Finally, our experimental phase microscope offered the opportunity to perform high 
resolution phase imaging in rat retinal flatmounts. For this purpose, we observed retinal 
capillaries and their surrounding cells, using microscope objectives with higher NA, in a 
correlative study between phase microscopy and fluorescence confocal microscopy. 
The retina from a healthy rat was first immuno-stained for NG2 to specifically detect 
pericytes in fluorescence. Using vessels as landmark, the same region was observed with 
confocal microscopy and with our experimental phase microscope set with a 0.45-NA 
objective (Fig. 7A-C). The comparisons of these images demonstrated that the proposed phase 
imaging method allows for the detection of pericytes, appearing as bright cells around retinal 
capillaries (Fig. 7A) exactly at the same location of NG2+ cells (Fig. 7B). The counter-
staining with DAPI (Fig. 7C) demonstrated that phase microscopy also allows for the 
detection of the nuclei cells in the observed layer. 
 Then, we observed the retina from an 11-month-old rat presenting retinal dystrophy 
associated with telangiectasias [27], using a 0.65NA objective in the phase microscope (Fig. 
7D) after the immuno-staining of Iba1, the marker of microglial cells (Fig. 7E, green), and of 
collagen IV to highlight vessels (Fig. 7E, red). The image correlation analysis between phase 
and confocal microscopy unequivocally demonstrated that high resolution phase imaging 
allows for the detection of these small cells as well. 
 
Discussion  
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Currently, the standard of care for retinal imaging is based on OCT and SLO. The first 
commercially available device integrating AO was based on flood illumination (rtx1TM, 
Imagine Eyes). We describe herein a novel microscopy concept and instrument for fast in vivo 
imaging of the retinal pigment epithelium with high contrast and cellular resolution.  
To our knowledge, no other imaging system allows for the visualization of RPE cells 
within a few seconds (Table 1). We see no technological barriers to create an easy-to-use 
clinical instrument because transscleral illumination requires the same accuracy in terms of 
beam alignment than transpupillary systems. On the contrary, for cellular-resolution imaging, 
AO SLO and AO OCT would be more difficult to implement in clinical setting for the 
following technical reasons. As presented in Table 1, their field of view of 2°×2° is close to 
five times smaller than the current field of view of the TOPI system. Since a large area of 
observation is more clinically relevant, five times more images would be required. Moreover, 
the use of a non-scanning system makes the acquisition process more stable under the effects 
of eye motion, especially because AO-SLO and AO-OCT require measurement time of 
several minutes (Table 1). For the latter, image distortion becomes a problem, which is less 
the case for a flood-illumination system, in which the full field of view is recorded 
simultaneously.  
The speed of an eye examination is crucial for patient’s comfort but more importantly 
when fixation capacity is reduced by retinal disease. The typical scan time for commercial 
clinical devices is a few seconds (2–3 s for Canon OCT-HS100, 2 s for Imagine Eyes rtx1, 3 s 
for Optovue AngioVue, 19–38 ms for B-Scan for Heidelberg Spectralis OCT, and 2 s for 
Zeiss Cirrus HD-OCT). With less than ten seconds required for TOPI acquisition, the 
obtained contrast was sufficient to perform quantitative analyses on RPE cells. The full field 
flood imaging technique combined with transscleral illumination establishes an imaging 
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modality that is several orders of magnitude faster than the AO-OCT technique when applied 
to weakly reflecting cells [15], [16]. This difference is essentially due to the fact that TOPI 
uses the scattered light from the back of the eye, which is much more reflective than the 
transparent cells.  
The oblique flood illumination enables fast full-field image acquisition that does not 
depend on biological processes, such as organelle motion [18], [15]. The light radiant 
exposure at the imaged area of the retina that is comparable with existing technologies. Fig. S 
9 shows the estimated retina radiant exposure level of competing AO imaging methods. For 
TOPI imaging, a single raw image requires an estimated radiant energy of 79 µJ/cm2 at the 
retina, while the 100-images sequence needed to obtain the final image yields 7.9 mJ/ cm2. 
These values are comparable to those of the commercial flood illumination device rtx1TM [2] 
and are lower than those used in a scanning system based on SLO or OCT. The projected spot 
on the sclera has a power density that satisfies the safety standard for skin and ocular tissues 
(see the Materials and Methods section). We note that, in all previous studies related to high-
resolution imaging of the retina, averaging of raw data is also necessary to obtain high SNR. 
 
In the present study, in vivo examinations of eleven healthy volunteers with our TOPI 
set up demonstrated the feasibility of fast imaging of RPE cells but also the possibility of 
quantifying them accurately. Importantly, the quality of RPE images was not impaired by 
individual skin phototypes and subsequent RPE pigmentation. TOPI examination also 
allowed accurate visualization of nerve and vascular fiber layers. Compared to images of 
retinal capillaries obtained with OCT angiography, the images of the smallest vasculature 
obtained with our method are independent of flow velocity and could thus provide 
complementary information.  
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Using an experimental microscope, the application of our phase imaging method to 
the observation of post-mortem human RPE validated the morphology of the RPE cells 
observed in volunteers. We have also shown that this imaging capability can be used to 
visualize all the layers of a pig neuroretina by combining multiple oblique illumination points 
and with appropriate modeling of the illumination function. Finally, the optimization of this 
setup for high resolution microscopy has shown that this new modality allows the 
visualization of the retinal capillaries and their surrounding cells, pericytes and microglia, 
without immuno-staining. 
 
The ability to image RPE cells within seconds in patients is of major interest to better 
understand the physiopathogenesis of retinal diseases and to follow the course of diseases that 
affect  the RPE such as age-related macular degeneration (AMD), retinitis pigmentosa [28] 
[29], or diabetic retinopathy [30].  Decrease in cell density and change in cell morphology 
could potentially be detectable at the early stage of AMD, before any complication has 
occurred [31] [32]. TOPI could also be used to detect effects of drugs and treatments at a 
cellular level, offering the opportunity to intervene before irreversible functional loss has 
occurred. Morphologic quantitative new endpoints could thus emerge.  In addition, recent 
medical studies have shown that Parkinson’s and Alzheimer’s diseases have an effect on the 
neuronal layers of the retina, [33] [34], which may increase the impact of the clinical use of 
this technology. 
In summary, TOPI holds promise for clinical use because it is, to the best of our 
knowledge, the only technique fast enough to image the RPE with high contrast and cellular 
resolution. Further clinical studies will clarify the limitations of this new imaging modality 
particularly in diseased states that distort the retinal layers organization. TOPI could be 
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combined with OCT methods, enabling not only to accelerate our understanding of retinal 
diseases and to define new morphological endpoints for therapeutic evaluation, but also the 
understanding of other neuro degenerative diseases.  
 
Materials and Methods 
Study on human subjects.  
The single-center study aimed at validating the performances of our phase imaging device 
adheres to the tenets of the Declaration of Helsinki. The protocol involving healthy human 
volunteer subjects was approved by the local Ethics Committee of the Swiss Department of 
Health on research involving human subjects (CER-VD N°2017-00976). Informed consent 
was obtained from the subjects. The left eyes of eleven healthy volunteers were imaged (four 
women, seven men) with an average age of 28 years (+/− 9) and having different skin 
pigmentations ranging from 1 to 6 on the Fitzpatrick scale were imaged [19]. 
Transscleral illumination principle 
Transscleral illumination of the fundus produces an oblique beam that reaches the 
posterior layers of the eye. The sclera transmits about 30% of the incident light at the imaging 
wavelength of 810 nm [17], and the absorption and reflectance of the RPE-choroid complex 
vary with its pigmentation [35] [36]. While crossing the sclera, the illumination light is 
scattered and diffused, producing a uniform highly-divergent beam that reaches obliquely the 
posterior retina and illuminates it evenly. The back-scattered light coming from all the retina 
layers is then captured through the pupil by the optical system. The achieved illumination 
angle is thus larger than what is obtainable via illumination through the pupil. We showed in a 
previous study that it creates a non-uniform excitation of the retinal spatial frequencies and 
enhances the contrast of phase objects [37] [38]. Additionally, the use of partially coherent 
light yields a system bandwidth that is twice the bandwidth obtainable using coherent light.  
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In vivo experimental design 
For the in vivo demonstration, the oblique illumination of the retina was produced 
using two Light Emitting Diodes (LED) with 810 nm nominal wavelength, 25 nm FWHM. 
The LED light beams are focused on the sclera at the pars-plana region to the temporal and 
nasal side of the iris (Fig. S 1). The light beams can be operated at the same time or 
alternatively to capture images with one or two illumination points. The obtained angle of 
illumination for each point was therefore approximately 35°. The subject’s head and eye were 
aligned with the system using an adjustable chin and forehead rest. 
The optical setup shown in Fig. S 1 consists in the following elements. The 
illumination arm was composed of a yellow fixation target, of a 756-nm superluminescent 
diode (SLD, Exalos), which provided a point source at the retinal plane for the aberration 
correction measurements, and of an 1050 nm low power infrared LED for illuminating the 
pupil uniformly. The imaging arm integrated a pupil camera, an AO feedback loop [39] (a 
Imagine Eyes Mirao 52e or Alpao DM97-15 deformable mirror and Imagine Eyes HASO4 
wavefront sensor), and an sCMOS camera for imaging the retina (ORCA Flash 4.0, 
Hamamatsu). The retinal sCMOS camera collected the light coming from the transscleral 
illumination to image the eye fundus through the pupil with a lateral sampling of 0.7 
µm/pixel. 
Once the position of the eye was aligned on the setup thanks to a chin and forehead 
rest, the retinal camera, which was mounted on a translation stage, was adjusted to focus on 
the targeted retinal layer. The real-time AO feedback loop was used for correcting the defocus 
accommodation of the eye (i.e., axial shifts of the plane), thus always locking a given imaging 
depth in the retina to a corresponding camera position. The depth sectioning is limited in this 
case by the depth of field, which is given by the pupil size and the aberrations of the eye. For 
                                                                                                                                                              
Page 17 of 45 
 
instance, for an aberration-free-6-mm pupil, the depth of field is 27 µm, yielding a value of 
0.17 NA (the equivalent focal distance of the eye lens in air is 17 mm), for a lateral resolution 
of 2.9 µm. A sequence of one hundred images at a given depth in the retina was acquired by 
successively turning the LED spots ON and OFF with an exposure time of 8 ms and a 
repetition rate of 11 Hz per illumination point. The image focus can be made at any depth in 
the retina by introducing a quadratic defocus term on the deformable mirror. Each layer took 
9 seconds to image. A hundred raw images for each illumination point were captured, for a 
total of 200 raw images for a single depth. For the RPE, an analysis based on its amplitude 
spectrum showed the possibility of obtaining a good SNR with much fewer raw images (2 
seconds would be sufficient, as illustrated in Fig. S 5). The raw images were then post-
processed, as explained in the “in-vivo image processing” section, to produce a single TOPI 
image. 
Light safety analysis 
The illumination beams are projected on the participant’s sclera when the eye is 
correctly aligned with the instrument. However, a complete safety analysis has to take into 
account any accidental projection of the beam on the skin, iris, cornea and lens to ensure no 
potential hazard of the system. To this end, the scleral, corneal, lens and retinal exposure were 
measured or calculated and compared with their respective exposure limits. We used the 
limits as expressed in the international standards for ophthalmic instrument optical safety ISO 
15004-2:2007 [40] for the ocular tissue and the skin limits given in the 2013 ICNIRP 
Guidelines on limits of exposure to incoherent visible and infrared radiation [41]. 
Eye exposure conditions: 
The beam minimum diameter is 3.5 mm at its focus point on the eye and the full 
converging angle is 0.37 radian. The pulse length is 8 ms and the repetition rate 11 Hz (duty 
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cycle of 0.088), with a measured pulse power of 250 mW at a center wavelength of 810 nm 
with FWHM of 25 nm. The consecutive acquisition time is no longer than 10 seconds. Based 
on the measured power and pulse specification, the eye exposure is straightforward 
calculated: 
Maximum pulsed irradiance at the sclera surface (8ms): EP = 2.598 W/cm2. 
Scleral radiant exposure for single pulse (1 pulse, 8ms): H1 = 21 mJ/cm2 
Time-average irradiance (11 Hz): EAV = 229 mW/cm2. 
Scleral radiant exposure for maximum exposure time (110 pulses, 10s): H110 = 2.287 J/cm2 
Retinal exposure: 
The light exposure reaching the underlying choroid and retina after crossing the sclera 
is less straightforward to compute. Only part of the light will transmit, and the beam will be 
scattered and spread by the tissue. The more accurate measurement on scleral transmission 
and absorption were done by Vogel et al. in 1991 [17]. They measured a ∼33% transmission 
(and ∼5% absorption) for a wavelength of 810 nm. As a conservative estimate, we will 
assume no diffusion nor beam spreading, thus giving a retinal exposure of 33% of the scleral 
exposure to compare with the limits. 
The retinal irradiance in case of accidental trans-pupil illumination is calculated thanks to the 
beam converging angle. The retinal image diameter dr and surface A is: 
dr = f·φ = (17 mm)(0.37 radian) = 6.29 mm  A = 0.31 cm2 
The irradiance is then directly found: E = 250 mW/0.31 cm2 = 0.805 W/cm2. 
The irradiance of the posterior retina in case of accidental trans-pupil exposure (0.805 W/cm2) 
is smaller than the irradiance of the retina underlying the sclera in case of intended 
transscleral exposure (33% * 2.598 = 0.857 W/cm2). The transscleral exposure and not the 
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accidental trans-pupil exposure is therefore the worst-case exposure scenario for the retina to 
compare with the limits. 
Applicable limits for Group 1 pulsed instrument [40]: 
Weighted retinal visible and infrared radiation radiant exposure limit: 
For 1 pulse (8ms): HVIR-R= 0.1605 J/cm2 
For 110 pulses (10s): HVIR-R= 10.4184 J/cm2 
Unweighted corneal and lenticular infrared radiation radiant exposure limit: 
For 1 pulse (8ms): HIR-CL= 0.5383 J/cm2 
For 110 pulses (10s): HIR-CL= 3.2009 J/cm2 
Unweighted anterior segment visible and infrared radiation radiant exposure limit (for 
convergent beam only): 
For 1 pulse (8ms): HVIR-AS= 7.4767 J/cm2 
For 110 pulses (10s): HVIR-AS= 44.4570 J/cm2 
Skin limits [41]: 
For 1 pulse (8ms): HSKIN= 0.5981 J/cm2 
For 110 pulses (10s): HSKIN= 3.5566 J/cm2 
The radiant exposure conditions of the eye for 1 pulse H1 and 110 pulses H110 
calculated above can be directly compared with the different limits. They are below all limits 
for Group 1 instrument (i.e. “ophthalmic instrument for which no potential light hazard 
exists” [40]) as well as below the ICNIRP skin limits [41]. The retina limits for our NIR 
exposure are not even attained if the sclera were considered with 100% transmission. The 
safety factor for retinal exposure is therefore at least a factor 20 (considering 33% 
transmission and thermal hazard weighting function R(λ)=0.6 for λ=810 nm).  
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The condition being the closest to the limit is the cornea and lenticular exposure in 
case of misalignment of the device, or a subject starring directly at the illumination beam. 
This event is very unlikely to happen but a safety factor of 1.5 prevent any potential adverse 
effect in that case. 
No explicit limits are provided for the sclera in the ISO 15004-2:2007 or ICNIRP 
guidelines. However, limits are provided for the anterior segment (cornea and lens) and for 
the skin. The sclera tissue itself can be considered in between skin and cornea. As it has a 
similar absorption coefficient for NIR as the cornea (but more scattering) [17], the sclera is 
expected to have a similar exposure limit. It is therefore reasonable to assume that sclera is 
safe if both the anterior segment limits and the limits for the more pigmented tissues such as 
skin are not attained, which it is the case for our instrument. As an additional safety evidence, 
far larger radiant exposure was sent on the sclera by Geffen et al. without noticing any 
adverse effect [42]. 
In vivo image processing 
Because of sudden eye micro-saccades during the 8ms acquisition time, some raw 
images had motion-blur artifacts. Therefore, only the 80% sharpest images were 
automatically or manually selected for averaging at each illumination point. The averaging of 
raw images was carried out to increase the SNR. Before averaging, the images were aligned 
in order to correct for the eye motions using the ImageJ plugin TurboReg, which considers the 
translations and the rotations of the images [43]. Once the images were aligned, they were 
then averaged, high-pass filtered (ImageJ bandpass filter with boundaries 1px-30px) and 
normalized with histogram stretching. After averaging, a single high-SNR dark-field image 
was obtained for each illumination point for a specific layer. The high-pass filter was used to 
remove a large part of the out-of-focus light. 
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Cell segmentation and quantification 
Cell segmentation was performed on several retinal layers to obtain quantitative 
morphology and density values. For the RPE layer, an automatic segmentation was performed 
via local minimum detection. Then, the Voronoi filter function was applied to create 
equidistant cell contours between the two nearest maxima, leading to RPE segmentation. 
Voronoi mapping is commonly used to map the retinal soma mosaic [15]. The coefficient of 
variation (CoV) [44], has been computed on subject S10 based on automatic RPE count and 
area measurements repeated five times under changed equipment and materials (two different 
deformable mirrors and two different head mounts were used) over five month. The results, 
plotted on Fig. S 10, give a CoV of 6.13% for RPE count and 6.44% for RPE area.  This 
standard measurement characterizes the reproducibility of the acquisition. The resulting 
values are considered good for a prototype device since higher values of CoV can be 
measured on commercial devices [44]. 
Statistical analysis 
Results were expressed as mean ± standard deviation. Student’s t-test was used to 
compare our data with that of the literature, when possible. A P value of <0.05 was 
considered statistically significant. 
 
Retinal ex vivo samples 
Flat-mounted retina-choroid complexes 
The two human-donor eyes were obtained from the eye bank of the Jules-Gonin Eye 
Hospital, in conformity with the Swiss Federal law on transplantation. It was collected for 
research purpose at 10 h post mortem, fixed in a 4% paraformaldehyde solution (PFA) for 24 
h, and then stored in 1% PFA at +4°C until it was analyzed. Pig eyes were obtained from a 
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local slaughterhouse, a few hours after the animals’ death. These eyes were fixed in 4% PFA 
for 24 h, and then stored in a phosphate-buffered saline (PBS) h at +4°C for one day before 
mounting.  
After washing in PBS, the anterior segment of the eyes and the vitreous were removed. The 
retina-choroid complexes were detached from the remaining posterior segments, and flat-
mounted in a solution made of PBS-glycerol (1:1). The human retina-choroid complexes were 
observed using a confocal microscope (Zeiss LSM710). The human and pig samples were also 
observed using our experimental phase microscope (as illustrated in Fig. S 6D). 
Cryosectioning 
One pig eye was kept for cryosectioning. After fixation and microdissection, the 
posterior segment of the eye was snap- frozen prior to frozen sectioning on a microtome-
cryostat. Frontal 10 um-thick sections were prepared and mounted on a glass coverslip. These 
sections were imaged using a digital holographic microscope (DHM) [45] and then with our 
phase microscope. 
Immunohistochemistry on neuroretinas 
Two pigmented rats from the animal facility of the Jules-Gonin Eye Hospital were 
used. Investigations were performed in accordance of the ARVO statement for the Use of 
Animals in Ophthalmic Vision Research. Our study was approved by the cantonal veterinary 
office (Authorization VD2928). Retinal morphology was examined in vivo, under ketamine / 
xylazine (80mg/kg and 8 mg/kg) anesthesia and after dilation, using a spectral domain OCT 
system adapted for rat eyes (Bioptigen). Animals were sacrificed via pentobarbital injection. 
After enucleation and fixation of the whole eyes during 2 h in 4% PFA, the anterior segments 
were discarded and the neuroretinas were carefully separated from the remaining posterior 
segment. Post-fixation was carried out for 10 min at −20°C in acetone.  
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For pericytes immunostaining, after rehydration in PBS supplemented with 0.5% 
Triton X100 and 10% fetal bovine serum (FBS) overnight at +4°C, the retinas were incubated 
for two days at +4°C with polyclonal rabbit anti-NG2 antibodies (1:200; AB5320, Merk 
Millipore). For microglia immunostaining, after rehydration in PBS supplemented with 0.5% 
Triton X100 and 10% FBS for 30 minutes at room temperature, the retinas were incubated 
overnight at +4 °C with a rabbit anti-iba1 (1:200; Wako) and a goat anti-collagen IV (1:100, 
Serotec) antibodies diluted in the same buffer. After washing, the neuroretinas were incubated 
with the appropriate antibody (Alexa-488-conjugated goat anti rabbit IgG, 1:250; donkey anti-
goat A633, 1:400; Invitrogen), diluted in PBS supplemented with 0.1% Triton X100 and 10% 
FBS, for 2 h at room temperature. After washing, the tissues were stained for 10 min with 4’, 
6-Diamidino-2-Phenyl-Indole (DAPI, 1:10 000), washed again, and flat-mounted in PBS-
glycerol (1:1). The neuroretinas were examined with a confocal microscope (Zeiss LSM 710), 
and then with our phase microscope. 
Ex vivo experimental design 
Our experimental phase microscope is illustrated in Fig. S 6. A total of four different 
LEDs were placed equally spaced around a microscope objective to produce four different 
illumination points. The sample was placed below the microscope objective (MO) and imaged 
using a CMOS camera using the MO and an achromatic doublet as a tube lens. A scattering 
layer of translucent commercial tape was used between each LED and the sample to increase 
the extent of illumination light and to mimic the scattering caused by the sclera. The sample 
was moved vertically to change the imaging layer depth. Depending on the NA of the MO, 
the exposure time varied between 1 ms and 20 ms. For each illumination point, a total of ten 
raw images were averaged to increase the SNR. A total of four averaged dark-field images 
(one for each points) were obtained for each depth. Then, the processing steps described 
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below were carried out to produce either differential phase contrast (DPC) images or a single 
phase-contrast image.  
Ex vivo image processing and phase reconstruction 
An image of the sample is recorded for each illumination point and a final quantitative 
phase image is reconstructed following the method described in [38]. Phase images can be 
reconstructed using the following principle: at least two pictures with intensities I(α) and 
I(α+180), captured with two different symmetric illumination polar angles (α and α+180°), 
are required. A DPC image can be then obtained according to:  
    	  	                                                             
Using several illumination points, multiple DPC images are produced. By combining 
these different DPC images of the same object, it is possible to obtain a quantitative phase 
image of the object thanks to the reconstruction process described in [46]. Finally, the 
reconstruction process of the phase is performed [47] [46] [38]. 
The reconstruction process is a Tikhonov regularization process with a known transfer 
function. The absorption transfer function is supposed to be identical for the different 
illumination points, meaning that it cancels out after the subtraction. The phase transfer 
function was calculated using the linearized imaging model presented by Tian and Waller 
[46].  
Code availability 
The code for performing the reconstruction process may be requested from the 
authors.    
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Figures and Tables 
 
 
 
Fig. 1: Illumination of the retinal layers provided via transscleral illumination. (A) Light 
transmission into the eye. The light is first transmitted through the sclera, the retina pigment epithelium (RPE), 
and the neuroretina. After travelling through the vitreous humor and the retina, it impinges on the RPE layer. Here, 
by backscattering off, the RPE generates a new illumination beam. This secondary illumination provides a 
transmission light that propagates through the transparent media, i.e., the neuroretina and its translucent cells, the 
vitreous, the eye lens, and, then, the anterior segment of the eye. (B) Illustration of the translucent vascular, 
neuronal and glial cells of the retina. (C) Histological cut of the retinal layers, the choroid, and the sclera. GCL: 
ganglion cells layer; INL: inner nuclear layer; IPL: inner plexiform layer; IS/OS: inner and outer segments of the 
photoreceptors; NFL: nerve fiber layer; ONL: outer nuclear layer; OPL: outer plexiform layer.  
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Fig. 2. In vivo full-field (4.4°x4.4°) image of the retinal pigment epithelium (RPE) of a healthy 
volunteer taken with TOPI. The image of the left eye of the subject S9 was taken at an eccentricity of 6.7° 
from the fovea. (A) The RPE image is the average of 100 raw retinal images taken in 9 seconds to increase the 
Signal over Noise Ratio. A nice mosaic of RPE cells is visible where the individual cell somas appear dark due to 
the absorbing pigment within the cell body. The cells are partially masked under a lower spatial frequency 
background modulation with varying intensity. This modulation is coming from the non-uniform pigmentation of 
the epithelium and the out-of-focus signal from the choroid. Scale bar is 1° or 300 μm.  (B) The original RPE 
image is cropped and high-pass filtered to remove the out of focus light and have a more uniform RPE cell mosaic  
(C) SLO fundus image showing the location of the TOPI image. 
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Fig. 3. In vivo retinal pigment epithelium TOPI quantification of eleven healthy volunteers (S1 to 
S11). (A) Quantification of RPE cell area versus the eccentricity with respect to the fovea. Quantification of RPE 
cell density versus the eccentricity with respect to the fovea (B) and age of the participants (C).  The phototype of 
the subjects ranged from 1 to 6 on the Fitzpatrick scale [19].  
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Fig. 4: Microcapillaries and nerve fiber layer TOPI images of subject S10 taken at different 
eccentricities. Each cropped image has a 3°x3° Field Of View, scale bar is 0.5° or 150 μm. (A) SLO fundus image 
showing the location of each TOPI image crop. (B-C) Microcapillaries being few microns thick are visible even 
if no blood flow is present thanks to the dark field effect of the oblique illumination. (D-E-F) Large axons bundles 
of 30-50 μm are clearly identifiable when looking at the nerve fiber layer. The bundles are well aligned and directed 
toward the optical nerve, as expected. 
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Fig. 5: Comparison between in vivo images from a trans-pupil flood illumination commercial 
system (rtx1TM, Imagine Eyes; Top) and a temporal trans-scleral illumination TOPI image (Bottom). (A, 
D) At the nerve fiber layer level (z=270 µm), the shape of nerve is detected with both modalities. (B, E) At the 
photoreceptor level (z=0 µm), the cones are well visible with high contrast and appear hyper-reflective in the 
rtx1 image due to light coupling inside the cells (Stiles-Crawford effect). They are barely visible in the TOPI 
image because no reflection is produced by the oblique illumination. (C, F) At the RPE level (z=200 µm), on the 
rtx1 trans-pupil image, no RPE cells are visible because their signal is buried below the high reflection coming 
from the out-of-focus photoreceptors, whereas, on the TOPI image, a nice RPE cell mosaic is visible. The somas 
appear dark because of the pigments composing the cells.  
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Fig. 6: (A – L) In-depth scan of a flat-mounted fixed pig retina-choroid complex obtained via 
phase imaging. (A, C, E, G, I, K) Phase images. (B, D,F,H, J, L) Phase images with digitally tagged cells and 
structures. Nerve fiber layer, z = 10 µm. Ganglion cell layer, z = 35 µm. Inner plexiform layer, z = 57 µm. Inner 
nuclear layer, z = 90 um.  Outer nuclear layer, z = 138 µm. Inner / outer photoreceptors segments interface, z = 
160 µm. Scale bars = 50 µm. (M) Cell densities versus depth corresponding to  A – L. Blue curves: measured 
data in this study. Magenta: density range of ganglion cells obtained from [25]. Green: density range of cones 
obtained from [26]. Dark green: density range of cones obtained from [24]. GCL: ganglion cell layer; INL: 
inner nuclear layer; IPL: inner plexiform layer; NFL: nerve fiber layer; ONL: outer nuclear layer; OPL: outer 
plexiform layer; PR: interface between the inner and outer segments of the photoreceptors. 
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Fig. 7: Image correlation analysis between high resolution phase microscopy and fluorescence 
confocal microscopy of retinal vessels and their surrounding cells. (A-C) Pericytes visualization in retina 
from a healthy rat aged 3 months. Retinal phase images (A) were compared with fluorescence microscopy 
images of the retina immunostained for NG2 (green in B and C) and counter-stained with DAPI (blue in C). 
Cells highlighted with white arrowheads in the phase image were localized exactly where the pericytes were 
detected using fluorescence confocal microscopy. (D-E) Microglial cells visualization in retina from an 11-
month-old rat presenting retinal dystrophy associated with telangiectasias.  Retinal phase images (D) were 
compared with fluorescence microscopy images of the retina immunostained with antibodies against Iba1 (green 
in E) and collagen IV (red in E).  Magnifications of three cells in both imaging modalities exemplified the 
detection of microglial cells using high resolution phase imaging. Ramified quiescent microglia as well as 
reactive microglia, with a round cell body (arrows), were observed. 
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Table 1: Comparison of the proposed method with state of the art commercial 
devices or laboratory prototypes. 1 Computational adaptive optics. 2 Includes 
autofluorescence, confocal, split detector and offset aperture SLO systems. 3 The limiting 
speed is the x,y scanning speed. 
 
 
Fig. S 1. Schematic of our in vivo phase imaging system. The digital photography represents 
transscleral illuminations by means of focused beams on the sclera. Light is then transmitted inside the eyeball. 
After scattering off the eye fundus, the light passing through the retinal cell layers is collected through the pupil 
of the eye. The optical setup includes an adaptive optics loop to correct the aberration of the eye. DM: Deformable 
mirror; LED: light-emitting diode; SLD: superluminescent diode; WFS: wavefront sensor. At the bottom right is 
a representation of the fields of view obtained via state-of-the-art methods (black, see Table 1 for correspondence) 
and TOPI (blue). 
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Fig. S 2. In vivo TOPI images of two distinct retinal layers of two healthy volunteers S4 (12° 
eccentricity from the fovea) and S11 (8° and 5° eccentricity from the fovea). (A, D) ganglion cells layers 
(z=200 µm), (B, E) small crops showing the yellow region of interest on A and D, (C, F) retinal pigment epithelium 
(z=0 µm),.  
 
 
 
Fig. S 3. Fourier analysis of an RPE layer image centered at 7° from the fovea. (Left) Dark-field 
image that was high-pass filtered to enhance the visualization. (Center) Axial profile of the spectrum. (Right) 
Spectrum of the left image cropped at a row to row spacing of 6.8 µm. The peak signature of the RPE signal was 
located at 13.8 µm, which is consistent with the values found in the literature. 
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Fig. S 4: Representation of the maximum eccentricities of our in vivo TOPI device. (A) Subject S9, 
left eye fundus as seen using a scanning laser ophthalmoscope (Optos). In-vivo TOPI at NFL level placed on top 
of the large FOV SLO image. Subject S10 left eye. On the vertical axis, TOPI images are located at ±15°. On the 
horizontal axis, images are located at ±15°. The yellow rectangle illustrates the wide field of view stitched to obtain 
a 27.4° × 3.5° image shown in (B, full resolution image available).  The green cross indicates the fovea. (C) TOPI 
crop images of 0.5° × 0.5° taken at the RPE level at different eccentricities. The individual RPE cells appear in 
dark with bright edges and are clearly identifiable on most part of the image. Note that the RPE cells below the 
retinal vessels are hidden.  
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Fig. S 5. Averaging of the retinal pigment epithelium layer image centered at 7° from the fovea. 
(Top, Bottom right) Phase images were acquired from two illumination points at 12 Hz. The dark-field images 
were aligned before averaging. (Bottom Left) Impact on the SNR based on the power spectrum analysis. 
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Fig. S 6. Experimental set up for ex vivo observations. (A–C) Schematics of the imaged samples. (A) 
Intensity USAF target sample mounted on top of a scattering surface (paper) for assessing the modulation transfer 
function of our optical system. Incoming light back-scatters off the paper. (B) Frontal frozen sections of a pig 
neuroretina, mounted on a glass slide. A scattering surface (paper) is attached to the bottom side of the glass slide 
in order to provide back-scattering light. (C) Flat-mounted “retina - choroid” complex placed on a glass slide. The 
light back-scatters from the RPE-choroid layer (D) Experimental microscope for phase imaging. LED light 
illuminates the sample from multiple directions. The backscattered light effectively becomes a forward beam that 
illuminates the transparent phase layers in the transmission geometry before reaching the microscope objective 
(10×, 0.25NA). An imaging lens then makes an image of the sample on a camera. 
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Fig. S 7: Ex vivo imaging of (A) the USAF intensity target, (B) a pig neuroretina section, and (C) a 
human flat-mounted retina-choroid complex. (A) Intensity image of the USAF intensity target. (Left) Dark-
field image of the USAF intensity target obtained via single-LED illumination. (Right) Plot of the theoretical and 
experimental modulation transfer functions obtained from the image. Red dots correspond to the contrasts of the 
elements of groups 8 and 9 of the USAF target. (B) Images of a 10-µm-thick frontal frozen section of pig 
neuroretina at the inner nuclear layer level. (Left) Phase image obtained using a digital holographic microscope. 
(Center) Phase image obtained using the proposed method. (Right) Horizontal cross section plot of quantitative 
phase comparison. Scale bars = 30 µm. (C) Images of a human flat-mounted fixed retina-choroid complex at the 
nerve fiber layer level. (Left-middle) Reflectance confocal images taken with 0.8-NA and 0.3-NA objectives, 
respectively. (Right) Phase image taken with a 0.25-NA objective. Scale bars = 50 µm.  
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Fig. S 8. Comparison of in vivo and ex vivo dark-field images of the RPE layer. (Left) In vivo human 
RPE dark-field image acquired with a ~5 mm diameter pupil and illuminated using a LED with an 810-nm peak 
wavelength. (Right) Ex vivo human RPE registered with a NA of 0.15 and illuminated using an LED with an 830-
nm peak wavelength. 
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Fig. S 9. Estimated radiant exposure at the imaged retinal area. Circles show the energy for raw 
image or volume acquisition, while triangles show the energy needed to obtain a final image resulting from the 
average of several raw images. AO: Adaptive optics; CAO: Computational AO; ICG: Indocyanine Green; FF: Full 
Field; OCT: Optical Coherence Tomography; SLO: Scanning Laser Ophthalmoscopy; SS: Swept Source; TOPI: 
Transcleral Oblique Phase Imaging. 
 
 
 
 
Fig. S 10. In-vivo RPE cells count and area over 5 month at 4° eccentricity for a 0.96°×0.96° 
region of interest, on subject S10. 
 
